Christ Lutheran Church
Goal: Share the story of Jesus and the ELCA by engaging with 1 million new people as we grow the church together. Purpose: Activate each of us so more people know the way of Jesus and discover community, justice and love. Vision: A world experiencing the difference God?s grace and love in Christ make for all people and creation.
ICO
810378479
Web
Sign in to see organisation website
Traffic
59409
From Social media
News about from their social media (Facebook and X).
Data about organisation
Interesting nearby
Interesting organisations close by to residence of Christ Lutheran Church
God's work.
God's work.
Join us and make a difference for the future!
Eduo.org makes finding trustworthy nonprofits refreshingly simple.
Michelle
I stumbled on Eduo by accident and ended up spending hours learning about different charities across the world. It’s like a global map of goodness
Barbara
A brilliant resource for anyone who wants to do good more effectively.
Joanna
Finally, a clear and organized way to explore local and global charities.
Barbara
Eduo.org makes finding trustworthy nonprofits refreshingly simple.
Daniel
Clean, community-driven, and full of heart — love it.
Stacy
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News
Zuzana
2025-10-25
Exciting news from Nunavut! 🎉 NTI has launched a groundbreaking $135M Inuit-led plan for affordable housing, creating the Igluvut Corporation. This initiative, run by Inuit for Inuit, is a historic step towards better living conditions in the community! 🏠❤️ #GoodNews #InuitHousing #CommunityFirst
NTI releases $135M Inuit-led plan for affordable housing in Nunavut
Yahoo
Like Comment
Joanna
2025-10-25
Exciting news in the fight against Sjögren's disease! 🎉 Nipocalimab showed significant promise in reducing disease activity and severity in a recent study. This breakthrough from Johnson & Johnson gives hope to many patients in the Czech Republic and beyond. Let's celebrate advancements in healthcare! 💪💙 #GoodNews #HealthInnovation #SjögrensDisease
Published in The Lancet: Nipocalimab significantly decreased Sjögren's disease (SjD) activity and severity through substantial reduction in Sjögren's-related autoantibodies - Johnson & Johnson (NYSE:JNJ)
Benzinga
Like Comment
